אולנזאפין דקסל 5 מ"ג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

OLANZAPINE 5 MG

Disponível em:

DEXCEL PHARMA TECHNOLOGIES LTD

Código ATC:

N05AH03

Forma farmacêutica:

TABLETS

Via de administração:

PER OS

Fabricado por:

DEXCEL LTD

Grupo terapêutico:

OLANZAPINE

Indicações terapêuticas:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Data de autorização:

2012-05-01